HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allyson Price Selected Research

B-Cell Prolymphocytic Leukemia

1/2021Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allyson Price Research Topics

Disease

3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 11/2019
1B-Cell Prolymphocytic Leukemia
01/2021
1Residual Neoplasm
01/2021

Drug/Important Bio-Agent (IBA)

1venetoclaxIBA
01/2021
1ibrutinibIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2020

Therapy/Procedure

2Therapeutics
01/2020 - 11/2019